Melisa Tecik

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Acute Myeloid Leukemia

Peritoneal Dialysis

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Current treatment options in oncology

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors. Current treatment options in oncology 25 (6) (2024)
Melisa Tecik, Aysun Adan
Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches. OncoTargets and therapy 15 (2022)